The role of PPAR-γ in macrophage differentiation and cholesterol uptake

Nature Medicine

Volumn 7, Issue 1, 2001, Pages 41-47

  Moore, Kathryn J ^a,b   Rosen, Evan D ^b,c   Fitzgerald, Michael L ^a,b   Randow, Felix ^a,b   Andersson, Lorna P ^a,b   Altshuler, David ^a,d   Milstone, David S ^b,e   Mortensen, Richard M ^f   Spiegelman, Bruce M ^b,c   Freeman, Mason W ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE; CD36 ANTIGEN; CYTOKINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER RECEPTOR; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FOAM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ANIMALS; ANTIGENS, CD36; BASE SEQUENCE; CELL DIFFERENTIATION; CHOLESTEROL; DNA PROBES; HYPOGLYCEMIC AGENTS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0035139016     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/83328     Document Type: Article

References (47)

1. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
2. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling
3. Peroxisome proliferator-activated receptor γ. A key regulator of adipogenesis and systemic insulin sensitivity
4. Expression and function of PPAR-γ in rat and human vascular smooth muscle cells
5. The nuclear receptor PPAR-γ and immunoregulation: PPAR-γ mediates inhibition of helper T cell responses
6. 2 is a ligand for the adipocyte determination factor PPAR-γ
7. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR-γ)
8. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
9. PPAR-γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
10. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR-γ
11. The peroxisome proliferator activated receptor-γ is a negative regulator of macrophage activation
12. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
13. Macrophages in human atheroma contain PPAR-γ differentiation-dependent peroxisomal proliferator-activated receptor γ (PPAR-γ) expression and reduction of MMP-9 activity through PPAR-γ activation in mononuclear phagocytes in vitro
14. Expression of the peroxisome proliferator-activated receptor γ (PPAR-γ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoproteins
15. CLA-1/SR-B1 is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors
16. Roles of PPARs in health and disease
17. Cyclopentenone prostaglandins - New allies in the war on inflammation
18. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of lκB kinase
19. 2 inhibits multiple steps in the NFkappa B signaling pathway
20. 14prostaglandin J2 inhibits the β-2 integrin-dependent oxidative burst: Involvement of a mechanism distinct from peroxisome proliferator-activated receptor γ ligation
21. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators
22. PPAR-γ in monocytes: Less pain, any gain?
23. PPAR-γ is required for placental, cardiac, and adipose tissue development
24. PPAR-γ is required for the differentiation of adipose tissue in vivo and in vitro
25. PPAR-γ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
26. In vitro-differentiated embryonic stem cell macrophages: A model system for studying atherosclerosis-associated macrophage functions
27. Activation of peroxisome proliferator-activated receptor γ does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro or in vivo
28. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
29. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ
30. Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function
31. Structural and functional characterization of the human CD36 gene promoter: Identification of a proximal PEBP2/CBF site
32. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
33. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
34. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL
35. Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation
36. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
37. Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
38. Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The troglitazone study group
39. Inhibition of oxidation of low density lipoprotein by troglitazone
40. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus
41. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
42. Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats
43. An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors
44. Simultaneous Cre catalyzed recombination of two alleles to restore neomycin sensitivity and facilitate homozygous mutations
45. Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse
46. Analysis of a Chinese hamster ovary cell mutant with defective mobilization of cholesterol from the plasma membrane to the endoplasmic reticulum
47. Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors